Granahan Investment Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$128K Buy
2019
Q3
$917K Buy
2019
Q2
$1.48M Sell
2019
Q1
$813K Buy
2018
Q4
$247K Sell
2018
Q3
$1.25M Buy
2018
Q2
$1.93M Buy